This capital injection will expedite the development and commercialisation of Okami's catheter-based technologies for ...

Okami Medical has closed a financing round, raising $32.5m led by Vensana Capital, with contributions from US Venture Partners and other industry veterans. This capital injection will expedite the ...

To-date, Okami has developed the LOBO ® Vascular Occlusion System and the SENDERO ® Microcatheter. The LOBO Vascular Occlusion System is uniquely designed to provide interventional physicians ...

Okami, which makes minimally invasive products to control blood flows to arteries, said the financing will support the development and commercialization of its first two products, the LOBO Vascular ...

Okami was launched by medical device incubator Inceptus Medical. To date, the company has developed the Lobo (low-profile braided occluder) vascular occlusion system and the Sendero microcatheter.

To-date, Okami has developed the LOBO ® Vascular Occlusion System and the SENDERO ® Microcatheter. The LOBO Vascular Occlusion System is uniquely designed to provide interventional physicians with a ...

To-date, Okami has developed the LOBO® Vascular Occlusion System and the SENDERO® Microcatheter. The LOBO Vascular Occlusion System is uniquely designed to provide interventional ...